Applied Dna Sciences Stock Fundamentals
| APDN Stock | USD 2.26 0.40 15.04% |
Applied DNA Sciences fundamentals help investors to digest information that contributes to Applied DNA's financial success or failures. It also enables traders to predict the movement of Applied Stock. The fundamental analysis module provides a way to measure Applied DNA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Applied DNA stock.
Applied |
Applied DNA Sciences Company Current Valuation Analysis
Applied DNA's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Applied DNA Current Valuation | (5.18 M) |
Most of Applied DNA's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Applied DNA Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Applied DNA Sciences has a Current Valuation of (5.18 Million). This is 100.04% lower than that of the Electronic Equipment, Instruments & Components sector and 100.07% lower than that of the Information Technology industry. The current valuation for all United States stocks is 100.03% higher than that of the company.
Applied DNA Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Applied DNA's current stock value. Our valuation model uses many indicators to compare Applied DNA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Applied DNA competition to find correlations between indicators driving Applied DNA's intrinsic value. More Info.Applied DNA Sciences is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Applied DNA's earnings, one of the primary drivers of an investment's value.Applied Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Applied DNA's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Applied DNA could also be used in its relative valuation, which is a method of valuing Applied DNA by comparing valuation metrics of similar companies.Applied DNA is currently under evaluation in current valuation category among its peers.
Applied Fundamentals
| Return On Equity | -1.03 | ||||
| Return On Asset | -0.64 | ||||
| Profit Margin | (2.28) % | ||||
| Operating Margin | (2.48) % | ||||
| Current Valuation | (5.18 M) | ||||
| Shares Outstanding | 55.19 M | ||||
| Shares Owned By Insiders | 19.47 % | ||||
| Shares Owned By Institutions | 26.90 % | ||||
| Number Of Shares Shorted | 5.61 M | ||||
| Price To Earning | (5.06) X | ||||
| Price To Book | 0.27 X | ||||
| Price To Sales | 0.78 X | ||||
| Revenue | 3.43 M | ||||
| Gross Profit | 1.47 M | ||||
| EBITDA | (14.02 M) | ||||
| Net Income | (7.09 M) | ||||
| Cash And Equivalents | 4.68 M | ||||
| Cash Per Share | 0.36 X | ||||
| Total Debt | 739.16 K | ||||
| Debt To Equity | 0.15 % | ||||
| Current Ratio | 2.16 X | ||||
| Book Value Per Share | 0.24 X | ||||
| Cash Flow From Operations | (13.71 M) | ||||
| Short Ratio | 1.58 X | ||||
| Earnings Per Share | (0.65) X | ||||
| Target Price | 1.5 | ||||
| Number Of Employees | 46 | ||||
| Beta | 0.42 | ||||
| Market Capitalization | 2.93 M | ||||
| Total Asset | 12.79 M | ||||
| Retained Earnings | (309.67 M) | ||||
| Working Capital | 5.65 M | ||||
| Current Asset | 11.35 M | ||||
| Current Liabilities | 4.08 M | ||||
| Net Asset | 12.79 M |
About Applied DNA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Applied DNA Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Applied DNA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Applied DNA Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York. Applied Dna operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 78 people.
Pair Trading with Applied DNA
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Applied DNA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Applied DNA will appreciate offsetting losses from the drop in the long position's value.Moving against Applied Stock
The ability to find closely correlated positions to Applied DNA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Applied DNA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Applied DNA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Applied DNA Sciences to buy it.
The correlation of Applied DNA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Applied DNA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Applied DNA Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Applied DNA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Applied DNA Piotroski F Score and Applied DNA Altman Z Score analysis. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.